SkinDermic® is a company dedicated to the discovery and the development of next generation first-in-class molecules against infectious and inflammatory diseases in dermatology and new generation of dermo-cosmetics products.

  • Our vision: to develop and market safe and efficient therapeutic solutions in dermatology and cosmetics.
  • Our company is focused on infectious and inflammatory dermatological diseases and dermo-cosmetics.

SkinDermic® business strategy is to partner its proprietary drug candidates with pharmaceutical, biotech or cosmetics companies for development, manufacturing and commercialization of its novel drugs.